Admin. (2014). What if HPV does NOT cause cervical cancer? SANEVAX. Retrieved from http://sanevax.org/hpv-not-cause-cervical-cancer/
It appears that Gardasil via its Al adjuvant and HPV antigens has the ability to trigger neuroinflammation and autoimmune reactions, further leading to behavioral changes.
The full extent of the Gardasil scandal needs to be assessed: everyone knew when this vaccine was released on the American market that it would prove to be worthless! Diane Harper, a major opinion leader in the United States, was one of the first to blow the whistle, pointing out the fraud and scam of it all.
Gardasil is useless and costs a fortune! In addition, decision-makers at all levels are aware of it!
Cases of Guillain-Barré syndrome, paralysis of the lower limbs, vaccine-induced MS and vaccine-induced encephalitis can be found, whatever the vaccine.
I predict that Gardasil will become the greatest medical scandal of all times because at some point in time, the evidence will add up to prove that this vaccine, technical and scientific feat that it may be, has absolutely no effect on cervical cancer and that all the very many adverse effects which destroy lives and even kill, serve no other purpose than to generate profit for the manufacturers.
There is far too much financial interest for these medicines to be withdrawn.
The new piece explains how Dr. Palefsky “cites selectively and conveniently” when he states that there is no increase in the risk of a variety of complications reported to follow HPV vaccines.
The scientists clarify:
“In particular, there was a nearly 2.5‑10 times greater risk of acquiring GBS within 6 weeks after quadrivalent [Gardasil] vaccination when compared with general population. In addition, quadrivalent [Gardasil] vaccination was associated with approximately 8.5 times more emergency department visits, 12.5 times more hospitalizations, 10 times more life‑threatening events and 26.5 times more disability than meningococcal C vaccination.”
And perhaps their most illuminating remark is this conclusion:
“We remain of the considered opinion that health policy planners in India [and we, TGG would argue around the world] would be well advised to carefully assimilate independent opinion on this subject that is not influenced by vaccine manufacturers, who stand to gain enormously from implementation of this intervention in vast populations.”
We documented here the evidence of the potential of the HPV vaccine to trigger a life-disabling autoimmune condition. The increasing number of similar reports of post HPV vaccine-linked autoimmunity and the uncertainty of long-term clinical benefits of HPV vaccination are a matter of public health that warrants further rigorous inquiry.
The recent Gardasil study by the CDC claims that the vaccine has significantly reduced HPV infections. The authors’ claim bears little resemblance to the study’s results. Here’s an analysis demonstrating that, in reality, no conclusions can be drawn—that the study’s results are inconsistent, based on non-matched samples, and mixed the groups being compared
Some of their advertising campaign slogans, such as "cervical cancer kills x women per year" and "your daughter could become one less life affected by cervical cancer," seemed more designed to promote fear rather than evidence-based decision making about the potential benefits of the vaccine. Although, conflicts of interests do not necessarily mean that the product itself is faulty, marketing claims should be carefully examined against factual science data. Currently Gardasil vaccination is strongly recommended by the U.S. and other health authorities while public concerns about safety and efficacy of the vaccine appear to be increasing. This discrepancy leads to some important questions that need to be resolved. The current review examines key issues of this debate in light of currently available research evidence.
This event could hold potential implications for population health and prompts further inquiry
The resulting topological conformational changes may affect a region shared by many HPV genotypes, for example at the primer-binding site for the degenerate MY09 primer, or may affect a region of a specific genotype, for example at the degenerate MY11 primer-binding site of the HPV-16 L1 gene DNA. DNA conformational changes induced by a particulate aluminum-based adjuvant may have stabilized the residual HPV-16 L1 gene DNA fragments in an injectable vaccine and prevented their enzymatic degradation in a vaccine recipient
The results from our IHC examination of brain tissue specimens from two young women who died following vaccination with the qHPV vaccine Gardasil showed strong evidence of an autoimmune vasculitis triggered by the cross-reactive HPV-16L1 antibodies binding to the wall of cerebral blood vessels (Figures 1 and 2)
Although policymakers acknowledge the utility of manufacturers' involvement in vaccination policymaking, industry lobbying that is overly aggressive, not fully transparent, or not divorced from financial contributions to lawmakers risks undermining the prospects for legislation to foster uptake of new vaccines